[Drug information. Therapeutic main group: agents for the treatment of vertigo. Behahistine (Betaserc)].
D001621:Betahistine / Q000627:therapeutic use*; D006801:Humans; D008575:Meniere Disease / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use*; D014717:Vertigo / Q000188:drug therapy*
D011725:Pyridines; D001621:Betahistine
Laegemiddelinformation. Terapeutisk hovedgruppe: midler til behandling af svimmelhed. Betahistin (Betaserc).